CAS: 2245072-21-1
LIT-001
CAS:2245072-21-1
LIT-001 improves social interaction in a mouse model of autism.It is the first nonpeptide oxytocin …
Formula:
C30H34F3N7O4S
Purity:
96.88% - 98.25%
Color and Shape:
Solid
Molecular weight:
645.7
Ref: TM-T11857
1mg | 71.00 € | ||
5mg | 154.00 € | ||
10mg | 276.00 € | ||
25mg | 437.00 € | ||
50mg | 645.00 € | ||
100mg | 917.00 € | ||
500mg | 1,789.00 € | ||
1mL*10mM (DMSO) | 214.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
(S)-2-(Dimethylcarbamothioyl)-N-(2-methyl-4-(1-methyl-1,4,5,10-tetrahydrobenzo[b]pyrazolo[3,4-e][1,4]diazepine-5-carbonyl)benzyl)pyrrolidine-1-carboxamide, Trifluoroacetate
CAS:2245072-21-1
Formula:
C30H33F3N7O4S
Purity:
98%
Molecular weight:
644.6877
Ref: IN-DA01V2NM
5mg | 99.00 € | ||
10mg | 136.00 € | ||
25mg | 192.00 € | ||
50mg | 323.00 € | ||
100mg | 516.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
LIT-001
CAS:2245072-21-1
LIT-001 is a new drug in development for the treatment of pain. LIT-001 is a …
Formula:
C30H34F3N7O4S
Purity:
Min. 95%
Molecular weight:
645.7 g/mol
Ref: 3D-VPD07221
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025